Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Liftactiv B3
Therapeutic Area : Dermatology
Study Phase : Phase II
Recipient : University of Miami
Deal Size : Inapplicable
Deal Type : Inapplicable
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Details : Liftactiv B3 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 14, 2022
Lead Product(s) : Liftactiv B3
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Recipient : University of Miami
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adapalene
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Adapalene is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 06, 2019
Lead Product(s) : Adapalene
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable